Related Experiment Video
Updated: Sep 27, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Steroid sensitive nephrotic syndrome
H M Nanjundaswamy1, K D Phadke
1Children's Kidney Care Centre, Department of Pediatrics, St. John's Medical College and Hospital, Bangalore, India.
Insights
Nephrotic syndrome in children, often minimal change disease, usually responds to steroids. However, frequent relapses or steroid dependence necessitate specialist care due to treatment risks.
Area of Science:
- Pediatric Nephrology
- Internal Medicine
- Clinical Pediatrics
Background:
- Nephrotic syndrome is a common pediatric kidney disorder.
- Minimal change disease accounts for most childhood cases, typically with a good prognosis.
- Over 90% of children with minimal change disease achieve remission with corticosteroid therapy (steroid-sensitive nephrotic syndrome).
Purpose of the Study:
- To summarize the clinical course and management of childhood nephrotic syndrome, particularly minimal change disease.
- To highlight the challenges in managing steroid-sensitive nephrotic syndrome with frequent relapses or steroid dependence.
- To emphasize the importance of specialist consultation for complex cases.
Main Methods:
- Review of existing literature on childhood nephrotic syndrome and minimal change disease.
- Analysis of treatment responses, relapse patterns, and long-term outcomes.
- Discussion of management strategies for steroid-sensitive and steroid-dependent nephrotic syndrome.
Main Results:
- Most children with minimal change disease respond well to corticosteroids.
- 40-60% of children experience frequent relapses or steroid dependence, requiring intensified treatment.
- High cumulative steroid toxicity and side effects from immunosuppressants are risks in these patients.
Conclusions:
- Children with frequent relapses or steroid dependence need pediatric nephrologist management.
- Despite a relapsing course, progression to end-stage renal disease in minimal change nephrotic syndrome is rare.
- Careful monitoring and management are crucial to minimize treatment-related complications.
Abstract:
Nephrotic syndrome in children is a common recurrent disease. Most of the cases are due to minimal change disease with a favourable outcome. More than 90% of children with minimal change disease respond to corticosteroid therapy (steroid sensitive nephrotic syndrome). 40-60% experience frequent relapses or have steroid dependence. These children require frequent corticosteroid therapy and/or immunomodulators or treatment with immunosuppressants, and are at high risk of cumulative steroid toxicity and side effects of cytotoxic therapy. Children with frequent relapses or steroid dependence should be managed in consultation with a pediatric nephrologist. Despite relapsing course, progression of minimal change nephrotic syndrome to end stage renal disease is extremely rare.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Drug Toxicity: Allergic Reactions
Diabetic Nephropathy
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
